| Year |
Citation |
Score |
| 2020 |
Lin AY, Rink JS, Karmali R, Xu J, Kocherginsky M, Thaxton CS, Gordon LI. Tri-ethylene glycol modified class B and class C CpG conjugated gold nanoparticles for the treatment of lymphoma. Nanomedicine : Nanotechnology, Biology, and Medicine. 102290. PMID 32798731 DOI: 10.1016/J.Nano.2020.102290 |
0.371 |
|
| 2019 |
Singh A, Nandwana V, Rink JS, Ryoo SR, Chen TH, Allen SD, Scott EA, Gordon LI, Thaxton CS, Dravid VP. Bio-Mimetic Magnetic Nanostructures: A Theranostic Platform Targeting Lipid Metabolism and Immune Response in Lymphoma. Acs Nano. PMID 31487458 DOI: 10.1021/Acsnano.9B03727 |
0.717 |
|
| 2019 |
Henrich SE, Hong BJ, Rink JS, Nguyen ST, Thaxton CS. Supramolecular assembly of high-density lipoprotein mimetic nanoparticles using lipid-conjugated core scaffolds. Journal of the American Chemical Society. PMID 31177775 DOI: 10.1021/Jacs.9B00651 |
0.327 |
|
| 2019 |
Rink J, Lin AY, Yang S, Behdad A, Karmali R, Thaxton CS, Gordon LI. Bio-Inspired Functional Lipoprotein-like Nanoparticles (Flip-NPs) Cause Cholesterol Starvation and Ferroptosis in B-Cell Lymphomas: Studies in Cell Lines, Xenograft Models and Primary Patient Samples Blood. 134: 2857-2857. DOI: 10.1182/Blood-2019-127805 |
0.417 |
|
| 2019 |
Lin AY, Rink J, Karmali R, Thaxton CS, Gordon LI. Engineering CpG Deoxynucleotide-Conjugated Gold Nanoparticles for Enhanced Anti-Lymphoma Effects in an Immune Competent Lymphoma Model Blood. 134: 1577-1577. DOI: 10.1182/Blood-2019-125308 |
0.369 |
|
| 2019 |
Rink JS, Yang S, Lin A, Karmali R, Thaxton CS, Gordon LI. Abstract 3618: The mechanism of functional lipoprotein-like nanoparticle (FLip-NP) induced lymphoma cell death Cancer Research. 79: 3618-3618. DOI: 10.1158/1538-7445.Am2019-3618 |
0.405 |
|
| 2018 |
Rink JS, Sun W, Misener S, Wang JJ, Zhang ZJ, Kibbe MR, Dravid VP, Venkatraman SS, Thaxton CS. Nitric Oxide-Delivering High-Density Lipoprotein-Like Nanoparticles as a Biomimetic Nanotherapy for Vascular Disease. Acs Applied Materials & Interfaces. PMID 29385802 DOI: 10.1021/Acsami.7B18525 |
0.345 |
|
| 2018 |
Bell JB, Rink JS, Eckerdt F, Clymer J, Goldman S, Thaxton CS, Platanias LC. HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma. Scientific Reports. 8: 1211. PMID 29352211 DOI: 10.1038/S41598-017-18100-8 |
0.378 |
|
| 2018 |
Rink J, Yang S, Cen O, Karmali R, Thaxton CS, Gordon LI. Inhibition of Pro-Survival Pathways in DLBCL Cells By Functional Lipoprotein-like Nanoparticles Blood. 132: 1668-1668. DOI: 10.1182/Blood-2018-99-119122 |
0.426 |
|
| 2018 |
Palekar RU, Rink JS, McMahon KM, Thaxton CS. Abstract 392: Nanoparticle-based Biosensors for Measuring Apolipoprotein A-I and HDL Function Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.392 |
0.444 |
|
| 2017 |
Plebanek MP, Bhaumik D, Bryce PJ, Thaxton CS. Scavenger Receptor Type B1 and Lipoprotein Nanoparticle Inhibit Myeloid Derived Suppressor Cells. Molecular Cancer Therapeutics. PMID 29282300 DOI: 10.1158/1535-7163.Mct-17-0981 |
0.308 |
|
| 2017 |
Rink JS, Yang S, Cen O, Taxter T, McMahon KM, Misener S, Behdad A, Longnecker R, Gordon LI, Thaxton CS. Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin. Molecular Pharmaceutics. PMID 28933554 DOI: 10.1021/Acs.Molpharmaceut.7B00710 |
0.346 |
|
| 2017 |
Meyers MW, Rink JS, Jiang Q, Kelly ME, Vercammen JM, Thaxton CS, Kibbe MR. Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions. Physiological Reports. 5. PMID 28242820 DOI: 10.14814/Phy2.13128 |
0.321 |
|
| 2017 |
Rink J, Cen O, McMahon KM, Misener S, Yang S, Thaxton CS, Gordon LI. Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled By Functional Lipoprotein Nanoparticles and the B Cell Receptor Inhibitor Ibrutinib: A Therapeutic Strategy Dependent on Cell of Origin (COO) Blood. 130: 576-576. DOI: 10.1182/Blood.V130.Suppl_1.576.576 |
0.398 |
|
| 2017 |
Nandwana V, Ryoo S, Kanthala S, McMahon KM, Rink JS, Li Y, Venkatraman SS, Thaxton CS, Dravid VP. High-Density Lipoprotein-like Magnetic Nanostructures (HDL-MNS): Theranostic Agents for Cardiovascular Disease Chemistry of Materials. 29: 2276-2282. DOI: 10.1021/Acs.Chemmater.6B05357 |
0.7 |
|
| 2017 |
Lai C, Sun W, Palekar RU, Thaxton CS, Schatz GC. Computational and Experimental Studies of Gold Nanoparticle Templated HDL-Like Nanoparticles for Cholesterol Metabolism Biophysical Journal. 112: 140a. DOI: 10.1016/J.Bpj.2016.11.772 |
0.327 |
|
| 2016 |
McMahon KM, Plebanek MP, Thaxton CS. Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted siRNA Delivery Vehicles. Advanced Functional Materials. 26: 7824-7835. PMID 28717350 DOI: 10.1002/Adfm.201602600 |
0.337 |
|
| 2016 |
Lai CT, Sun W, Palekar RU, Thaxton CS, Schatz GC. Molecular Dynamics Simulation and Experimental Studies of Gold Nanoparticle Templated HDL-like Nanoparticles for Cholesterol Metabolism Therapeutics. Acs Applied Materials & Interfaces. PMID 28001031 DOI: 10.1021/Acsami.6B12249 |
0.33 |
|
| 2016 |
Alhasan AH, Scott AW, Wu JJ, Feng G, Meeks JJ, Thaxton CS, Mirkin CA. Circulating microRNA signature for the diagnosis of very high-risk prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 27601638 DOI: 10.1073/Pnas.1611596113 |
0.716 |
|
| 2016 |
Angeloni NL, McMahon KM, Swaminathan S, Plebanek MP, Osman I, Volpert OV, Thaxton CS. Pathways for Modulating Exosome Lipids Identified By High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1. Scientific Reports. 6: 22915. PMID 26964503 DOI: 10.1038/Srep22915 |
0.361 |
|
| 2016 |
Rink JS, Misener S, Cen O, Yang S, Gordon LI, Thaxton CS. High Density Lipoprotein-like Nanoparticles Synergize with Akt and Btk Inhibitors to Induce Cell Death in Diffuse Large B Cell Lymphomas Blood. 128: 3022-3022. DOI: 10.1182/Blood.V128.22.3022.3022 |
0.414 |
|
| 2016 |
Wasserman MA, Rink J, Thaxton CS, Kibbe MR. Synthetically Engineered High-Density Lipoprotein Gold Nanoparticles Target to Vascular Injury after Systemic Intravascular Administration Journal of the American College of Surgeons. 223: S169. DOI: 10.1016/J.Jamcollsurg.2016.06.033 |
0.388 |
|
| 2015 |
Plebanek MP, Mutharasan RK, Volpert O, Matov A, Gatlin JC, Thaxton CS. Nanoparticle Targeting and Cholesterol Flux Through Scavenger Receptor Type B-1 Inhibits Cellular Exosome Uptake. Scientific Reports. 5: 15724. PMID 26511855 DOI: 10.1038/Srep15724 |
0.312 |
|
| 2015 |
McMahon KM, Foit L, Angeloni NL, Giles FJ, Gordon LI, Thaxton CS. Synthetic high-density lipoprotein-like nanoparticles as cancer therapy. Cancer Treatment and Research. 166: 129-50. PMID 25895867 DOI: 10.1007/978-3-319-16555-4_6 |
0.363 |
|
| 2015 |
Luthi AJ, Lyssenko NN, Quach D, McMahon KM, Millar JS, Vickers KC, Rader DJ, Phillips MC, Mirkin CA, Thaxton CS. Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein. Journal of Lipid Research. 56: 972-85. PMID 25652088 DOI: 10.1194/Jlr.M054635 |
0.78 |
|
| 2015 |
Foit L, Giles FJ, Gordon LI, Thaxton CS. Synthetic high-density lipoprotein-like nanoparticles for cancer therapy. Expert Review of Anticancer Therapy. 15: 27-34. PMID 25487833 DOI: 10.1586/14737140.2015.990889 |
0.418 |
|
| 2015 |
McMahon KM, Scielzo C, Scarfo L, Ranghetti P, Yang S, Gordon LI, Giles F, Thaxton CS, Ghia P. Synthetic High-Density Lipoprotein-like Nanoparticles (HDL NP) Cause Apoptosis and Enhance Killing By B-Cell Receptor and BCL-2 Inhibitors in Chronic Lymphocytic Leukemia (CLL) Blood. 126: 2949-2949. DOI: 10.1182/Blood.V126.23.2949.2949 |
0.443 |
|
| 2015 |
Rink JS, Yang S, Cen O, Ying F, Chae YK, Scholtens D, Moreira J, Chadburn A, Gordon LI, Thaxton CS. Scavenger Receptor Type B1 Is Essential for High Density Lipoprotein Nanoparticle Induced B-Cell Lymphoma Cell Death Blood. 126: 2756-2756. DOI: 10.1182/Blood.V126.23.2756.2756 |
0.365 |
|
| 2015 |
Chae YK, Pan A, Scholtens D, Yang S, Rink J, Thaxton CS, Gordon L. Abstract 3672: Expression patterns of scavenger receptor B-1 (SR-B1) to guide biomimetic HDL gold nanoparticle therapy Cancer Research. 75: 3672-3672. DOI: 10.1158/1538-7445.Am2015-3672 |
0.39 |
|
| 2015 |
Wasserman MA, Jiang Q, Rink J, Kibbe MR, Thaxton CS. Synthetically Engineered Targeted Gold Nanoparticles for the Prevention of Restenosis after Vascular Interventions Journal of the American College of Surgeons. 221: S185. DOI: 10.1016/J.Jamcollsurg.2015.07.440 |
0.342 |
|
| 2015 |
McMahon KM, Foit L, Angeloni NL, Giles FJ, Gordon LI, Thaxton CS. Synthetic high-density lipoprotein-like nanoparticles as cancer therapy Cancer Treatment and Research. 166: 129-150. DOI: 10.1007/978-3-319-16555-4_6 |
0.324 |
|
| 2014 |
Halo TL, McMahon KM, Angeloni NL, Xu Y, Wang W, Chinen AB, Malin D, Strekalova E, Cryns VL, Cheng C, Mirkin CA, Thaxton CS. NanoFlares for the detection, isolation, and culture of live tumor cells from human blood. Proceedings of the National Academy of Sciences of the United States of America. 111: 17104-9. PMID 25404304 DOI: 10.1073/Pnas.1418637111 |
0.744 |
|
| 2014 |
Tripathy S, Vinokour E, McMahon KM, Volpert OV, Thaxton CS. High Density Lipoprotein Nanoparticles Deliver RNAi to Endothelial Cells to Inhibit Angiogenesis. Particle & Particle Systems Characterization : Measurement and Description of Particle Properties and Behavior in Powders and Other Disperse Systems. 31: 1141-1150. PMID 25400330 DOI: 10.1002/Ppsc.201400036 |
0.311 |
|
| 2014 |
McMahon KM, Thaxton CS. High-density lipoproteins for the systemic delivery of short interfering RNA. Expert Opinion On Drug Delivery. 11: 231-47. PMID 24313310 DOI: 10.1517/17425247.2014.866089 |
0.353 |
|
| 2014 |
Halo TL, McMahon KM, Angeloni NL, Xu Y, Wang W, Chinen AB, Malin D, Strekalova E, Cryns VL, Cheng C, Mirkin CA, Thaxton CS. NanoFlares for the detection, isolation, and culture of live tumor cells from human blood Proceedings of the National Academy of Sciences of the United States of America. 111: 17104-17109. DOI: 10.1073/pnas.1418637111/-/DCSupplemental |
0.749 |
|
| 2014 |
Tripathy S, Vinokour E, McMahon KM, Volpert OV, Thaxton CS. High-Density lipoprotein nanoparticles deliver RNAi to endothelial cells to inhibit angiogenesis Particle and Particle Systems Characterization. 31: 1141-1150. DOI: 10.1002/ppsc.201400036 |
0.312 |
|
| 2013 |
Rink JS, McMahon KM, Zhang X, Chen X, Mirkin CA, Thaxton CS, Kaufman DB. Knockdown of intraislet IKKβ by spherical nucleic acid conjugates prevents cytokine-induced injury and enhances graft survival. Transplantation. 96: 877-84. PMID 24247900 DOI: 10.1097/Tp.0B013E3182A4190E |
0.357 |
|
| 2013 |
Yang S, Damiano MG, Zhang H, Tripathy S, Luthi AJ, Rink JS, Ugolkov AV, Singh AT, Dave SS, Gordon LI, Thaxton CS. Biomimetic, synthetic HDL nanostructures for lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 110: 2511-6. PMID 23345442 DOI: 10.1073/Pnas.1213657110 |
0.8 |
|
| 2013 |
Damiano MG, Mutharasan RK, Tripathy S, McMahon KM, Thaxton CS. Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery. Advanced Drug Delivery Reviews. 65: 649-62. PMID 22921597 DOI: 10.1016/J.Addr.2012.07.013 |
0.348 |
|
| 2012 |
Alhasan AH, Kim DY, Daniel WL, Watson E, Meeks JJ, Thaxton CS, Mirkin CA. Scanometric microRNA array profiling of prostate cancer markers using spherical nucleic acid-gold nanoparticle conjugates. Analytical Chemistry. 84: 4153-60. PMID 22489825 DOI: 10.1021/Ac3004055 |
0.761 |
|
| 2012 |
Luthi AJ, Zhang H, Kim D, Giljohann DA, Mirkin CA, Thaxton CS. Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux. Acs Nano. 6: 276-85. PMID 22117189 DOI: 10.1021/Nn2035457 |
0.771 |
|
| 2011 |
Kieger A, Wiester MJ, Procissi D, Parrish TB, Mirkin CA, Thaxton CS. Hybridization-induced "off-on" 19F-NMR signal probe release from DNA-functionalized gold nanoparticles. Small (Weinheim An Der Bergstrasse, Germany). 7: 1977-81. PMID 21661107 DOI: 10.1002/Smll.201100566 |
0.716 |
|
| 2011 |
McMahon KM, Mutharasan RK, Tripathy S, Veliceasa D, Bobeica M, Shumaker DK, Luthi AJ, Helfand BT, Ardehali H, Mirkin CA, Volpert O, Thaxton CS. Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. Nano Letters. 11: 1208-14. PMID 21319839 DOI: 10.1021/Nl1041947 |
0.803 |
|
| 2011 |
Kim DY, McGuire BB, Zhao LC, Loeb S, Le B, Dupree JM, Cooper PR, Kundu S, Thaxton CS, Mirkin CA, Catalona WJ. 304 PRELIMINARY EVALUATION OF SENSITIVITY AND SPECIFICITY OF A NANOTECHNOLOGY PSA ASSAY FOR DEFINING PROSTATE CANCER TREATMENT SUCCESS AND FAILURE Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.397 |
0.34 |
|
| 2011 |
Kim DY, McGuire BB, Zhao LC, Loeb S, Le B, Kundu S, Cooper PR, Banks JA, Thaxton CS, Mirkin CA, Catalona WJ. 1913 NANO-PSA IN PATIENTS WITH ADVERSE PATHOLOGICAL FEATURES Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.2051 |
0.33 |
|
| 2010 |
Luthi AJ, Patel PC, Ko CH, Mutharasan RK, Mirkin CA, Thaxton CS. Nanotechnology for synthetic high-density lipoproteins. Trends in Molecular Medicine. 16: 553-60. PMID 21087901 DOI: 10.1016/J.Molmed.2010.10.006 |
0.756 |
|
| 2010 |
Rink JS, McMahon KM, Chen X, Mirkin CA, Thaxton CS, Kaufman DB. Transfection of pancreatic islets using polyvalent DNA-functionalized gold nanoparticles. Surgery. 148: 335-45. PMID 20633730 DOI: 10.1016/J.Surg.2010.05.013 |
0.424 |
|
| 2010 |
Mouli S, Chung J, Eifler A, Lewandowski R, Ardehali H, Bentrem D, Larson A, Mirkin C, Thaxton C, Omary R. Abstract No. 71: Image-guided nanoembolization to target microRNA 210 in the VX2 rabbit model of liver cancer Journal of Vascular and Interventional Radiology. 21: S29. DOI: 10.1016/J.Jvir.2009.12.219 |
0.322 |
|
| 2010 |
Eifler A, Lewandowski R, Mouli S, Chung J, Bentrem D, Salem R, Ryu R, Mirkin C, Larson A, Thaxton C, Omary R. Abstract No. 70 [Cope]: Image-guided nanoembolization as a novel local therapy for pancreatic cancer: Feasibility in an animal model Journal of Vascular and Interventional Radiology. 21: S28. DOI: 10.1016/J.Jvir.2009.12.218 |
0.307 |
|
| 2010 |
Zhao LC, Kim DY, Le B, Alphs H, Helfand BT, Kan D, Smith ND, Mirkin CA, Thaxton CS, Loeb S, Catalona WJ. 575 NANOTECHNOLOGY PSA MEASUREMENTS CORRELATE WITH PROSTATE CANCER PATHOLOGY AND RESPONSE TO ADJUVANT TREATMENT Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.834 |
0.312 |
|
| 2010 |
Navai N, Giljohann DA, Zhao L, Helfand BT, Thaxton CS, Mirkin CA. 972 CREATION AND CHARACTERIZATION OF A THERAPEUTIC NANOPARTICLE PLATFORM FOR TREATMENT OF BLADDER CANCER: PRELIMINARY IN VITRO RESULTS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.1919 |
0.741 |
|
| 2010 |
Alphs H, O'Brien DC, Kan D, Le BV, Kim DY, Zhao LC, Loeb S, Smith ND, Mirkin CA, Thaxton CS, Cooper PR, Catalona WJ. 108 COMPARISON OF CONVENTIONAL PSA AND NANOTECHNOLOGY PSA IN INDIVIDUAL PROSTATE CANCER PATIENTS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.157 |
0.312 |
|
| 2009 |
Thaxton CS, Elghanian R, Thomas AD, Stoeva SI, Lee JS, Smith ND, Schaeffer AJ, Klocker H, Horninger W, Bartsch G, Mirkin CA. Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Proceedings of the National Academy of Sciences of the United States of America. 106: 18437-42. PMID 19841273 DOI: 10.1073/Pnas.0904719106 |
0.756 |
|
| 2009 |
Thaxton CS, Daniel WL, Giljohann DA, Thomas AD, Mirkin CA. Templated spherical high density lipoprotein nanoparticles. Journal of the American Chemical Society. 131: 1384-5. PMID 19133723 DOI: 10.1021/Ja808856Z |
0.801 |
|
| 2006 |
Jin R, Cao YC, Thaxton CS, Mirkin CA. Glass-bead-based parallel detection of DNA using composite Raman labels. Small (Weinheim An Der Bergstrasse, Germany). 2: 375-80. PMID 17193054 DOI: 10.1002/Smll.200500322 |
0.524 |
|
| 2006 |
Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, Mirkin CA. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science (New York, N.Y.). 312: 1027-30. PMID 16709779 DOI: 10.1126/Science.1125559 |
0.782 |
|
| 2006 |
Stoeva SI, Lee JS, Thaxton CS, Mirkin CA. Multiplexed DNA detection with biobarcoded nanoparticle probes. Angewandte Chemie (International Ed. in English). 45: 3303-6. PMID 16602131 DOI: 10.1002/Anie.200600124 |
0.796 |
|
| 2006 |
Bertin PA, Gibbs JM, Shen CK, Thaxton CS, Russin WA, Mirkin CA, Nguyen ST. Multifunctional polymeric nanoparticles from diverse bioactive agents. Journal of the American Chemical Society. 128: 4168-9. PMID 16568958 DOI: 10.1021/Ja056378K |
0.424 |
|
| 2006 |
Thaxton CS, Georganopoulou DG, Mirkin CA. Gold nanoparticle probes for the detection of nucleic acid targets. Clinica Chimica Acta; International Journal of Clinical Chemistry. 363: 120-6. PMID 16214124 DOI: 10.1016/J.Cccn.2005.05.042 |
0.765 |
|
| 2005 |
Cao YC, Jin R, Thaxton CS, Mirkin CA. A two-color-change, nanoparticle-based method for DNA detection. Talanta. 67: 449-55. PMID 18970188 DOI: 10.1016/J.Talanta.2005.06.063 |
0.616 |
|
| 2005 |
Thaxton CS, Hill HD, Georganopoulou DG, Stoeva SI, Mirkin CA. A bio-bar-code assay based upon dithiothreitol-induced oligonucleotide release. Analytical Chemistry. 77: 8174-8. PMID 16351173 DOI: 10.1021/Ac0514265 |
0.775 |
|
| 2005 |
Shaikh KA, Ryu KS, Goluch ED, Nam JM, Liu J, Thaxton CS, Chiesl TN, Barron AE, Lu Y, Mirkin CA, Liu C. A modular microfluidic architecture for integrated biochemical analysis. Proceedings of the National Academy of Sciences of the United States of America. 102: 9745-50. PMID 15985549 DOI: 10.1073/Pnas.0504082102 |
0.569 |
|
| 2005 |
Georganopoulou DG, Chang L, Nam JM, Thaxton CS, Mufson EJ, Klein WL, Mirkin CA. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 102: 2273-6. PMID 15695586 DOI: 10.1073/Pnas.0409336102 |
0.745 |
|
| 2005 |
Thaxton CS, Rosi NL, Mirkin CA. Optically and chemically encoded nanoparticle materials for DNA and protein detection Mrs Bulletin. 30: 376-380. |
0.599 |
|
| 2004 |
Mirkin CA, Thaxton CS, Rosi NL. Nanostructures in biodefense and molecular diagnostics. Expert Review of Molecular Diagnostics. 4: 749-51. PMID 15525216 DOI: 10.1586/14737159.4.6.749 |
0.581 |
|
| 2004 |
Rosi NL, Thaxton CS, Mirkin CA. Control of nanoparticle assembly by using DNA-modified diatom templates. Angewandte Chemie (International Ed. in English). 43: 5500-3. PMID 15484248 DOI: 10.1002/Anie.200460905 |
0.655 |
|
| 2003 |
Thaxton CS, Nam JM, Mirkin CA. PCR-like sensitivity for proteins with bio-bar-code amplification. Discovery Medicine. 3: 58-60. PMID 20705043 |
0.585 |
|
| 2003 |
Cao YC, Jin R, Nam JM, Thaxton CS, Mirkin CA. Raman dye-labeled nanoparticle probes for proteins. Journal of the American Chemical Society. 125: 14676-7. PMID 14640621 DOI: 10.1021/Ja0366235 |
0.654 |
|
| 2003 |
Nam JM, Thaxton CS, Mirkin CA. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science (New York, N.Y.). 301: 1884-6. PMID 14512622 DOI: 10.1126/Science.1088755 |
0.642 |
|
| Show low-probability matches. |